• Contact Us
    •

    Resource Center

    Feb 17, 2022
      |  Presentation

    Post Approval: Generics Track – Assessing the Potential for Hepatotoxicity for Combination Therapy of Valproate (VPA) and CBD using Quantitative Systems Toxicology (QST)

    Lakhani VV
    Conference: SLP MIDD+

    Presented by Vinal Lakhani at SLP MIDD+ Virtual Conference February 16th-17th, 2022

    Session Moderator: Elizabeth Ludwig

    Download Slides

     

    Click Here to View

    Contact Us About This Presentation

    Similar Resources

    Simulations Plus Presentation
    07/20/2022
    Complex Delivery Routes and Generics: The Next Frontier for PBBM/PBPK Modeling
    Spires J
    Keywords: bioequivalence, generic drugs, in vitro, in vivo, pbbm, PBPK modelingSoftware: GastroPlus®Conference: CRSDivision: Simulations Plus
    Read More Click Here to View
    Simulations Plus Presentation
    06/23/2022
    Data required to build a fit-for-purpose PBPK model: How much is necessary?
    Ketkar AR
    Keywords: biopredictive dissolution, modeling and simulation, PBPK modeling, physiological based biopharmaceutics models (PBBM)Software: ADMET Predictor®, DDDPlus™, GastroPlus®, MembranePlus™Conference: DISSODivision: Simulations Plus
    Read More Click Here to View
    Simulations Plus Presentation
    06/15/2022
    Predictive Dissolution Modeling with Clinically Relevant Specifications
    Suarez-Sharp S
    Keywords: biopharmaceutics, dissolution, pbbmConference: IFPACDivision: Simulations Plus
    Read More Click Here to View